Over the past few decades, amorphous solid dispersions (ASDs) have been of great interest to pharmaceutical scientists to address bioavailability issues associated with poorly water-soluble drugs. ASDs consist of an active pharmaceutical ingredient (API) that is typically dispersed in an inert polymeric matrix. Despite promising advantages, a major concern that has resulted in limited marketed formulations is the physical instability of these complex formulations. Physical instability is often manifested as phase heterogeneity, where the drug and carrier migrate and generate distinct phases, which can be a prelude to recrystallization. One important factor that dictates the physical stability of ASDs is the spatial distribution of API in th...
Current drug discovery techniques tend to identify potential new drug entities with more complex str...
Poorly water-soluble drugs pose a significant challenge to developability due to poor oral absorptio...
The preparation of amorphous solid dispersions (ASDs) has enabled the development of oral dosage for...
Over the past few decades, amorphous solid dispersions (ASDs) have been of great interest to pharmac...
Many pharmaceutical compounds being developed in recent years are poorly soluble in water. This has ...
Pharmaceutical amorphous solid dispersions (ASDs) represent a widely used technology to increase the...
Amorphous formulations, including amorphous solid dispersions (ASDs), consisting of the active pharm...
Amorphous drug delivery systems are increasingly utilized to enhance aqueous solubility and oral bio...
Amorphous solid dispersions have been widely applied to improve the oral bioavailability of BCS Clas...
Amorphous solid dispersions (ASDs) which are primarily comprised of drug(s) dispersed within a polym...
University of Minnesota Ph.D. dissertation. October 2016. Major: Pharmaceutics. Advisor: Dr. Raj Sur...
ABSTRACT: Purpose: Development of a method to assess the drug/polymer miscibility and stability of s...
Poor aqueous solubility of an active pharmaceutical ingredient (API) is a significant hurdle during ...
Amorphous solid dispersions (ASDs) are one of the frontier strategies to improve solubility and diss...
University of Minnesota Ph.D. dissertation. December 2020. Major: Pharmaceutics. Advisor: Raj Suryan...
Current drug discovery techniques tend to identify potential new drug entities with more complex str...
Poorly water-soluble drugs pose a significant challenge to developability due to poor oral absorptio...
The preparation of amorphous solid dispersions (ASDs) has enabled the development of oral dosage for...
Over the past few decades, amorphous solid dispersions (ASDs) have been of great interest to pharmac...
Many pharmaceutical compounds being developed in recent years are poorly soluble in water. This has ...
Pharmaceutical amorphous solid dispersions (ASDs) represent a widely used technology to increase the...
Amorphous formulations, including amorphous solid dispersions (ASDs), consisting of the active pharm...
Amorphous drug delivery systems are increasingly utilized to enhance aqueous solubility and oral bio...
Amorphous solid dispersions have been widely applied to improve the oral bioavailability of BCS Clas...
Amorphous solid dispersions (ASDs) which are primarily comprised of drug(s) dispersed within a polym...
University of Minnesota Ph.D. dissertation. October 2016. Major: Pharmaceutics. Advisor: Dr. Raj Sur...
ABSTRACT: Purpose: Development of a method to assess the drug/polymer miscibility and stability of s...
Poor aqueous solubility of an active pharmaceutical ingredient (API) is a significant hurdle during ...
Amorphous solid dispersions (ASDs) are one of the frontier strategies to improve solubility and diss...
University of Minnesota Ph.D. dissertation. December 2020. Major: Pharmaceutics. Advisor: Raj Suryan...
Current drug discovery techniques tend to identify potential new drug entities with more complex str...
Poorly water-soluble drugs pose a significant challenge to developability due to poor oral absorptio...
The preparation of amorphous solid dispersions (ASDs) has enabled the development of oral dosage for...